In 2017, the United
States Department of Health and Human
Services
declared the widespread misuse and abuse of prescription and illicit
opioids an epidemic. However, this epidemic dates back to the 1990s
when opioids were extensively prescribed for pain management. Currently,
opioids are still recommended for pain management, and given their
abuse potential, rapid screening is imperative for patient treatment.
Of particular importance is assessing pain management patient compliance,
where evaluating drug use is crucial for preventing opioid abuse and
potential overdoses. In this work, we utilized drift tube ion mobility
spectrometry coupled with mass spectrometry (DTIMS-MS) to develop
a rapid screening method for 33 target opioids and opioid urinary
metabolites. Collision cross section values were determined for all
target molecules using a flow-injection DTIMS-MS method, and clear
differentiation of 27 out of the 33 opioids without prior chromatographic
separation was observed when utilizing a high resolution demultiplexing
screening approach. An automated solid phase extraction (SPE) platform
was then coupled to DTIMS-MS for 10 s sample-to-sample analyses. This
SPE-IMS-MS approach enabled the rapid screening of urine samples for
opioids and presents a major improvement in sample throughput compared
to traditional chromatographic analyses coupled with MS, which routinely
take several minutes per sample. Overall, this vast reduction in analysis
time facilitates a faster turn-around for patient samples, providing
great benefits to clinical applications.